We bring you the latest news from the healthcare about the health care in the United Kingdom.

woensdag 26 september 2018

Latest content from npj Precision Oncology: 25 September 2018

If you are unable to see the message below, click here to view.
npj Precision Oncology

Table of Contents: September 2018

Review Article | 17 September 2018

Tumor evolution and chemoresistance in ovarian cancer

Soochi Kim, Youngjin Han, Se Ik Kim, Hee-Seung Kim, Seong Jin Kim et al.

npj Precision Oncology 2 , Article number: 20 |  doi: 10.1038/s41698-018-0063-0

Brief Communication | 03 September 2018

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia

A. Ljungars, L. MÃ¥rtensson, J. Mattsson, M. Kovacek, A. Sundberg et al.

npj Precision Oncology 2 , Article number: 18 |  doi: 10.1038/s41698-018-0061-2

Your email address is in the npj Precision Oncology mailing list.
You have been sent this alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: myaccount (You will need to log in to be recognised as a nature.com registrant)
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our customer feedback department
Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.
Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.
Springer Nature